About Careers MedBlog Contact us

Screening for Cancer is Effective on Repeat Participation

by Julia Samuel on January 9, 2015 at 10:54 AM
Font : A-A+

Screening for Cancer is Effective on Repeat Participation

A recent study investigated predictors of repeat participation in the NHS Bowel Cancer Screening Programme (BCSP). Most types of population-based cancer screening require repeat participation to be effective.

Guaiac fecal occult blood test (gFOBt) was performed as a biennial colorectal cancer-screening test in the BCSP in England for the age group of 60-74 years.


A total of 62,081 participants were aged 60-64 years at the time of the first invitation were recruited for the study. The main outcome was repeat participation at their second or third invitation.

Behavioural measures derived from screening records included late return of the gFOBt kit, compliance with follow-up investigations and previous screening participation.

Other potential predictors of repeat participation included results of individual test kit analysis (normal, weak positive, strong positive, spoilt) and the definitive result of the gFOBt screening episode (normal or abnormal). Age, sex and socioeconomic deprivation were also recorded.

Overall repeat uptake was 82% in the second and third invitations on an average. Late return of the test kit was consistently associated with lower uptake.

A definitive abnormal gFOBt result in the previous screening episode was a negative predictor of repeat uptake.

Weak positive and spoilt test kits were associated with lower repeat uptake, but were not consistently independent predictors in all invitation rounds or subgroups.

Among those with a definitive abnormal gFOBt result, noncompliance with follow-up in a previous screening episode was also associated with lower repeat uptake.

Behavioural markers and test results from previous screening episodes have been implicated in subsequent gFOBt uptake.

Source: Medindia


Recommended Reading

Latest Cancer News

Exploring the Role of Neutrophils in Immunotherapy
Neutrophils, the blood cell types are mobilized to fight cancer if they are appropriately engaged.
How Can Mouse Avatars Help Treat Multiple Myeloma?
The mouse avatars created help study and develop personalized treatments against blood cancer - myeloma.
Why Is Time of Day Important in Cancer Diagnosis and Treatment?
Chronotherapy (the sleep-wake cycle) is observed as a valuable alternative treatment in cancer diagnosis and treatment.
How Do Neutrophils Impact Pancreatic Cancer Treatment Resistance?
A nanoengineering platform targets neutrophils, the white blood cells without killing pancreatic cancer cells paving the way for effective treatments.
Could TKI Cancer Drugs Lead to Inflammatory Side Effects?
The mechanism by which the kinases cause inflammation has been discovered by scientists.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Screening for Cancer is Effective on Repeat Participation Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests